Evommune Inc. (EVMN) vs MacroGenics, Inc. (MGNX)
- Evommune Inc. EVMN 5.17 −12.82%
- MacroGenics, Inc. MGNX 3.25 −3.56%
Evommune Inc. and MacroGenics, Inc. are both Biotechnology companies. Evommune Inc. and MacroGenics, Inc. are of similar size ($215.2M and $214.7M). Evommune Inc. has the higher net margin (0.00% vs −7.97%) and the lower return on invested capital (−82.5% vs 0.00%). Across the 13 metrics below, Evommune Inc. leads on 7 and MacroGenics, Inc. on 6.
Valuation
Profitability
| Metric | EVMN | MGNX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 78.07% | 65.16% |
| Operating margin | 0.00% | (18.73%) | 0.00% |
| Net margin | 0.00% | (7.97%) | 0.00% |
| Free cash flow margin | 0.00% | (35.80%) | 0.00% |
| Return on equity | (141.99%) | (32.61%) | (56.36%) |
| Return on assets | (62.71%) | (4.94%) | (48.04%) |
| Return on invested capital | (82.46%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack